Showing results (611-620 of 678) with videos related to

Sort By:
Pageof 68
Cancers|April 3, 2021
Transposon Mutagenesis-Guided CRISPR/Cas9 Screening Strongly Implicates Dysregulation of Hippo/YAP Signaling in Malignant Peripheral Nerve Sheath Tumor DevelopmentGermán L Vélez-Reyes, Nicholas Koes, Ji Hae Ryu, et al.
Infection and Immunity|March 16, 2002
Safety and immunogenicity of a prototype enterotoxigenic Escherichia coli vaccine administered transcutaneouslyFernando Güereña-Burgueño, Eric R Hall, David N Taylor, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|September 4, 2012
A mouse diversity panel approach reveals the potential for clinical kidney injury due to DB289 not predicted by classical rodent modelsAlison H Harrill, Kristina D Desmet, Kristina K Wolf, et al.
The Journal of Heart Transplantation|March 1, 1987
Use of cyclosporine and ketoconazole without nephrotoxicity in two heart transplant recipientsT J Schroeder, D B Melvin, C W Clardy, et al.
Diabetes Care|October 29, 2010
Safety and efficacy of ranibizumab in diabetic macular edema (RESOLVE Study): a 12-month, randomized, controlled, double-masked, multicenter phase II studyPascale Massin, Francesco Bandello, Justus G Garweg, et al.
Nature Reviews. Cardiology|August 29, 2019
Saphenous vein grafts in contemporary coronary artery bypass graft surgeryEtem Caliskan, Domingos Ramos de Souza, Andreas Böning, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|April 4, 2025
Chronic, Battery-Free, Fully Implantable Multimodal Spinal Cord Stimulator for Pain Modulation in Small Animal ModelsAllie J Widman, Taron Bashar, Alex Burton, et al.
Vaccine|January 18, 2003
Oral immunization of adult volunteers with microencapsulated enterotoxigenic Escherichia coli (ETEC) CS6 antigenDavid E Katz, Arthur J DeLorimier, Marcia K Wolf, et al.
Science (New York, N.Y.)|June 22, 2019
Akkermansia muciniphila induces intestinal adaptive immune responses during homeostasisEduard Ansaldo, Leianna C Slayden, Krystal L Ching, et al.
Molecular Cancer Therapeutics|August 13, 2009
A novel hTERT promoter-driven E1A therapeutic for ovarian cancerXiaoming Xie, Jennifer L Hsu, Min-Gew Choi, et al.
Pageof 68